Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults

Two antigenically distinct influenza B lineage viruses (Yamagata/Victoria) have been co-circulating globally since the mid-1980s. The quadrivalent influenza vaccine (QIV) may provide better protection against unpredictable B strains. We conducted a randomized, double-blind, phase III trial to evalua...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joon Young Song, Jacob Lee, Heung Jeong Woo, Seong-Heon Wie, Jin Soo Lee, Shin Woo Kim, Tae Hyong Kim, Sook-In Jung, Ji Yun Noh, Won Suk Choi, Hee Jin Cheong, Woo Joo Kim
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2019-03-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	inactivated quadrivalent influenza vaccine influenza b victoria lineage yamagata lineage
Accés en línia:	http://dx.doi.org/10.1080/21645515.2018.1536589
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!